Reference Literature
Covid-19
Covid-19
Academic information and documents are separated by category.
Click the appropriate button.
Click the appropriate button.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
||
| The Lingzhi or Reishi Medicinal Mushroom Ganoderma lucidum (Agaricomycetes) Can Combat Cytokine Storm and Other COVID-19 Related Pathologies: A Review. |
| Rowaiye AB, Ogugua AJ, Bur D, Wood T, Labbo Z, Chukwu C, Afolabi FJ, Nwonu EJ, Agbalalah T. |
| Int J Med Mushrooms. 2023;25(5):1-15. doi: 10.1615/IntJMedMushrooms.2023048109. |
| GMI, a fungal immunomodulatory protein, ameliorates SARS-CoV-2 envelope protein-induced inflammation in macrophages via inhibition of MAPK pathway. |
| Lin ZH, Yeh H, Lo HC, Hua WJ, Ni MY, Wang LK, Chang TT, Yang MH, Lin TY. |
| Int J Biol Macromol. 2023 Jun 30;241:124648. doi: 10.1016/j.ijbiomac.2023.124648. Epub 2023 Apr 28. |
| Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion. |
| Ho HPT, Vo DNK, Lin TY, Hung JN, Chiu YH, Tsai MH. |
| Biomed Pharmacother. 2022 Nov;155:113766. doi: 10.1016/j.biopha.2022.113766. Epub 2022 Sep 28. |
| Lucidenic acid A inhibits the binding of hACE2 receptor with spike protein to prevent SARS-CoV-2 invasion. |
| Xu J, Yang W, Pan Y, Xu H, He L, Zheng B, Xie Y, Wu X. |
| Food Chem Toxicol. 2022 Nov;169:113438. doi: 10.1016/j.fct.2022.113438. Epub 2022 Sep 28. |
| GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus. |
| Yeh H, Vo DNK, Lin ZH, Ho HPT, Hua WJ, Qiu WL, Tsai MH, Lin TY. |
| Phytomedicine. 2022 Aug;103:154215. doi: 10.1016/j.phymed.2022.154215. Epub 2022 May 28. |
| Rationalization of Mushroom-Based Preventive and Therapeutic Approaches to COVID-19: Review. |
| Rahman MA, Rahman MS, Bashir NMB, Mia R, Hossain A, Saha SK, Kakon AJ, Sarker NC. |
| Int J Med Mushrooms. 2021;23(5):1-11. doi: 10.1615/IntJMedMushrooms.2021038285. |
| Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection |
| Jia-Tsrong Jan 1, Ting-Jen Rachel Cheng 1, Yu-Pu Juang 2, Hsiu-Hua Ma 1, Ying-Ta Wu 1, Wen-Bin Yang 1, Cheng-Wei Cheng 1, Xiaorui Chen 1, Ting-Hung Chou 3, Jiun-Jie Shie 3, Wei-Chieh Cheng 1, Rong-Jie Chein 3, Shi-Shan Mao 1, Pi-Hui Liang 4 2, Che Ma 4, Shang-Cheng Hung 4, Chi-Huey Wong 4 |
| Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):e2021579118. doi: 10.1073/pnas.2021579118. |